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on “restricted” status in 36.4% of hospitals. Guidelines for 
care of patients with ADHF were used in the emergency depart-
ment (ED), inpatient care units, and outpatient clinics in 
18.6%, 43.0% and 8.5% of hospitals respectively. Overall,
ADHF care including general treatment as well as speciﬁc use of
nesiritide was deemed to be appropriate in the majority of
patients but nearly twice as many respondents perceived the
management of ADHF and speciﬁc use of nesiritide was inap-
propriate in ED compared to the inpatient treatment. Only
41.1% of the respondents reported following Braunwald rec-
ommendations for the use of nesiritide. CONCLUSION: A
sizable percentage of responding community hospitals did not
have guidelines for treatment of ADHF despite existence of such
in the literature. There are potential opportunities for improve-
ment in the general treatment of ADHF as well as use of nesiri-
tide in ADHF especially in the ED or observation unit versus
inpatient.
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OBJECTIVES: To evaluate outcomes of clopidogrel use follow-
ing hospitalization for ACS in patients who had stent placement
during the index hospitalization. METHODS: Retrospective
administrative claims data from a geographically diverse US
managed care organization (MCO) were used to identify patients
≥ 18 years of age, hospitalized with ACS diagnoses, treated with
stent placement, and ﬁlling clopidogrel prescriptions within 7
days of discharge between 2000 and 2004 using ICD-9, CPT-4,
and NDC codes. Exclusion criteria included ACS, anticoagulant
or antiplatelet therapy 12 months prior to the index event, and
use of anticoagulant or antiplatelet agents except aspirin and
clopidogrel in the follow-up period. Clopidogrel exposure and
non-exposure time following the index hospitalization were
determined based on prescription data. Outcomes: Hospitaliza-
tion for ischemic events (IE) and hospitalization or ER visits for
bleeding episodes (BE) were determined using ICD-9 codes. Cox
proportional-hazard regression controlled for clopidogrel expo-
sure, age, gender, diabetes, hypertension, percutaneous translu-
minal coronary angioplasty (PTCA), and coronary artery bypass
graft (CABG). RESULTS: A total of 9129 subjects, 79.5% male,
mean age 54.6 ± 9 years, were identiﬁed. Mean follow-up time
was 514 days, mean clopidogrel exposure time was 210 days,
and mean non-exposure time was 303 days. IE rate was 8.7%
during exposure and 9.1% during non-exposure; BE rates were
0.8% and 0.7%, respectively. Hazard ratio (HR) for IE during
clopidogrel exposure was 0.87 [95% CI, 0.78–0.96; P = 0.007].
Other signiﬁcant HRs were male gender (0.79; P < 0.001); dia-
betes (1.32; P < 0.001); and hypertension (1.13; P < 0.017). HR
for BE during clopidogrel exposure was 1.46 [95% CI,
1.09–1.97; P = 0.012]; other signiﬁcant HRs were hypertension
(1.35; P = 0.041) and age (1.04; P < 0.001). CONCLUSION:
This conﬁrms clinical study ﬁndings that clopidogrel use reduces
subsequent IE in ACS patients treated with stent placement, with
a bleeding risk comparable to that observed in the CURE study.
Longer treatment with clopidogrel could potentially reduce addi-
tional IE.
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OBJECTIVES: To illustrate a graphical approach for summariz-
ing patterns of drug use and resource utilization surrounding
clinical outcomes. METHODS: Partitioned bar charts, displayed
on horizontal axis at times of clinical measurements, display per-
centages of patients taking different drug classes prior to each
clinical measure. Superimposed on charts are plots of average
clinical values, age, and duration/visits since diagnosis. Boot-
strapping is used to provide conﬁdence intervals for clinical and
utilization estimates. RESULTS: The clin-o-gram will be illus-
trated using demographic, prescription, and longitudinal blood
pressure measurments on hypertensive patients from the General
Electric Electronic Medical Record captured in the Centricity
Physician Ofﬁce system. The descriptive clin-o-gram plots
provide clues for subsequent inferential analysis including mar-
ginal mean and pooled logisitc regression over vists. CONCLU-
SION: With increased availability of clinical outcomes comes
need to visualize patterns of drug use relative to changes in the
outcomes. Statistical models of changing clinical measures as
function of changing drug utilization need to be preceded by
graphical summaries.
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OBJECTIVES: To investigate patterns in antibiotic prescribing
for patients undergoing cardiovascular surgery to determine
whether there are differences between physicians with high rates
of infection compared to physicians with low rates of infection.
METHODS: All cardiovascular surgeries from a mid-sized
southern hospital over a 2-year period were examined (approx-
imately 2100 surgeries). A cross-tabulation between physician
and patient infections was performed to identify those physicians
with a low (under 6%) and a high (over 6%) infection rates.
Information from the pharmacy database relating to all patients
in the cardiovascular database was extracted, and all antibiotic
prescriptions were identiﬁed. The data mining techniques of
association rules and kernel density estimation were used to
investigate prescribing patterns between the two groups of physi-
cians. RESULTS: While the surgeons did not seem to differ in
their use of cephalosporins, they differed considerable in their
use of ﬂuoroquinolones. Low infection physicians made more
frequent use of Cipro while high infection physicians tended to
make more use Levaquin. In addition, some patients received up
to eight different antiobiotics as inpatients before, during, and
after cardiovascular surgery. CONCLUSION: Data mining 
techniques that have been developed for business applications
can be used to investigate physician decisions and their impact
on patient outcomes. Variability in physician decisions in the
absence of treatment guidelines can be investigated observation-
ally, and meaningful results obtained. In this application, there
are differences in antibiotic use related to infection rates. These
differences should be examined and a consensus reached for pre-
scribing habits.
